1.
HER2/neu expression status of post BCG recurrent non-muscle-invasive bladder urothelial carcinomas in relation to their primary ones. Arch Ital Urol Androl [Internet]. 2023 May 30 [cited 2026 May 22];95(2). Available from: https://www.pagepressjournals.org/aiua/article/view/11313